The majority of our experience exploring the association between plasma FGF23 levels, morbidity, and mortality from infectious causes comes from studies performed long before the SARS-CoV-2 pandemic and included infection-related hospitalizations caused by both bacterial and viral infections [32-33]. The gene discussed is FGF23; the disease is viral infectious disease.